- Service Name
Accelerator™ Drug Development
- Industry
Pharmaceutical, Contract Development and Manufacturing Organization (CDMO), Clinical Research Organization (CRO), Life Sciences
- Main Value Proposition
The primary value offered is the ability to accelerate the drug development journey through integrated services and a strategic partnership that enhances efficiency and effectiveness.
- Description
Accelerator™ Drug Development is a comprehensive service offered by Thermo Fisher Scientific that supports pharmaceutical and biotech companies in bringing treatments to market faster. It combines contract development and manufacturing organization (CDMO) and clinical research organization (CRO) capabilities to streamline the drug development process.
- Key Features
End-to-end solutions for drug development; Global expertise in pharmaceutical manufacturing; Tailored clinical trial services; Advanced digital enablement for smarter drug development
- Use Cases
Primary scenarios where the service is most valuable include drug development for new therapies, clinical trial logistics, and manufacturing of complex biologics and advanced therapies.
- Competitive advantages
Comprehensive end-to-end solutions that cover all phases of drug development; Strong global presence with over 60 locations, ensuring local expertise and support; Commitment to transparency and collaboration throughout the development process
- Strengths
Key strengths include a robust global supply network, extensive experience in cGMP manufacturing, and a focus on partnership and collaboration to meet client needs.
- Positioning
The service positions itself as a strategic partner in the pharmaceutical industry, emphasizing trust, collaboration, and expertise to navigate the complexities of drug development.
- Audience
The target users include pharmaceutical companies, biotech firms, and life sciences organizations looking for reliable partners in drug development and manufacturing.
- CTA
Schedule a meeting
- Tags
Drug Development
CDMO
CRO
Clinical Trials
- Tagline
Discover the future of drug development at DCAT Week 2025
- Tone of Voice
Professional, supportive, collaborative
- Differentiation
What makes this service unique is its combination of CDMO and CRO capabilities, providing a seamless experience from early development to commercial manufacturing, supported by a global network and advanced digital solutions.
- Brand Positioning
Thermo Fisher Scientific, through Patheon, identifies itself as a leader in the CDMO space, committed to innovation and excellence in supporting the pharmaceutical and biotech industries.
- Founded
1974-01-01